N- [ (3S)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake in- hibitors

Details for Australian Patent Application No. 2005308534 (hide)

Owner Pfizer Inc.

Inventors Stobie, Alan; Whitlock, Gavin Alistair; Wakenhut, Florian; Ryckmans, Thomas; Fish, Paul Vincent

Agent Shelston IP

Pub. Number AU-A-2005308534

PCT Pub. Number WO2006/056884

Priority 0425766.3 23.11.04 GB

Filing date 18 November 2005

Wipo publication date 1 June 2006

International Classifications

C07D 207/14 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/056884 Priority application(s): WO2006/056884

16 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005308538-Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders

2005308530-Immediate ready implementation of virtually congestion free guaranteed service capable network: external internet NextGenTCP (square wave form) TCP friendly san